The average one-year price target for Palisade Bio (NasdaqCM:PALI) has been revised to $10.20 / share. This is a decrease of 12.09% from the prior estimate of $11.60 dated April 12, 2026. The price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results